CD44 and familial pancreatic carcinoma: As for pancreatic cancer HPC-Y5 cells, although the ratio of CD44+/CD24+ cells did not exhibit a significant change due to the small size of the double-positive cell subset, the subpopulation of CD44−/CD24− cells was increased following fisetin treatment (Additional file 1: Figure S1a,b).